טוען...
Proton pump inhibitor use and cancer mortality
Proton pump inhibitors (PPIs) are commonly used as a supplement to cancer therapy. Yet, their effect on cancer mortality is largely unknown. Using data from Danish nationwide registries and Cox proportional hazards models, we estimated hazard ratios with 95% confidence intervals (CIs) for cancer-spe...
שמור ב:
| הוצא לאור ב: | Int J Cancer |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611279/ https://ncbi.nlm.nih.gov/pubmed/29658114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31529 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|